دورية أكاديمية
Bacteremia and Mortality among Patients with Nontunneled and Tunneled Catheters for Hemodialysis.
| العنوان: | Bacteremia and Mortality among Patients with Nontunneled and Tunneled Catheters for Hemodialysis. |
|---|---|
| المؤلفون: | Lima CS; Postgraduate Program in Medical Sciences at the Faculty of Medicine, FAMED, Federal University of Alagoas-UFAL, Maceió, Brazil., Vaz FB; Ribamar Vaz Institute of Nephrology, Santa Casa de Misericórdia of Maceió, Maceió, Brazil., Campos RP; Postgraduate Program in Medical Sciences at the Faculty of Medicine, FAMED, Federal University of Alagoas-UFAL, Maceió, Brazil.; Ribamar Vaz Institute of Nephrology, Santa Casa de Misericórdia of Maceió, Maceió, Brazil. |
| المصدر: | International journal of nephrology [Int J Nephrol] 2024 Feb 06; Vol. 2024, pp. 3292667. Date of Electronic Publication: 2024 Feb 06 (Print Publication: 2024). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Hindawi Country of Publication: United States NLM ID: 101546753 Publication Model: eCollection Cited Medium: Print ISSN: 2090-214X (Print) NLM ISO Abbreviation: Int J Nephrol Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Publication: 2011- : New York : Hindawi Original Publication: London : SAGE-Hindawi Access to Research |
| مستخلص: | Introduction: Central venous catheters for hemodialysis (HD) can be nontunneled catheters (NTC) or tunneled catheters (TC). Bacteremia and dysfunction are complications that can impact morbidity and mortality. We decided to compare the rates of bacteremia and dysfunction between NTC and TC and patient survival 90 days after catheter insertion. Methods: Retrospective cohort to evaluate catheters inserted between January 2011 and December 2020 in a tertiary hospital. Catheters in patients with end-stage chronic kidney disease were included. Patients with acute kidney injury, catheters that lasted less than three HD sessions, and patients who died within one week after insertion were excluded. Bacteremia and dysfunction rates, bacteremia-free survival, and dysfunction-free survival were investigated. Multivariable analysis was performed using a Cox proportional hazards regression model for patient survival at 90 days. Results: 670 catheters were analyzed in 287 patients, 422 NTC (63%), and 248 TC (37%). The rates of confirmed bacteremia per 1,000 catheter-days were 1.19 for NTC and 0.20 for TC ( p < 0.0001). The confirmed or possible bacteremia rates were 2.27 and 0.37 per 1,000 catheter-days for NTC and TC, respectively ( p < 0.0001). The dysfunction rates were 3.96 and 0.86 for NTC and TC, respectively ( p < 0.0001). Patient survival at 90 days was higher in the TC group than the NTC group (96.8% vs. 89.1%; p < 0.0001). Conclusion: We found lower rates of bacteremia and dysfunction for TC and demonstrated that using NTC affects patient mortality. Competing Interests: The authors declare that they have no conflicts of interest. (Copyright © 2024 Carla Santos De Lima et al.) |
| References: | Int J Nephrol Renovasc Dis. 2014 Jul 08;7:281-94. (PMID: 25045278) Arch Med Res. 2006 Apr;37(3):348-52. (PMID: 16513483) J Bras Nefrol. 2020 May 20;42(2):191-200. (PMID: 32459279) J Am Soc Nephrol. 2011 Oct;22(10):1939-45. (PMID: 21852579) Semin Dial. 2018 May;31(3):258-267. (PMID: 29624739) Am J Kidney Dis. 2020 Apr;75(4 Suppl 2):S1-S164. (PMID: 32778223) J Ren Nutr. 2013 Mar;23(2):91-7. (PMID: 22633987) Lancet. 2017 Mar 25;389(10075):1238-1252. (PMID: 27887750) Saudi J Kidney Dis Transpl. 2019 Sep-Oct;30(5):1187-1189. (PMID: 31696863) Int J Nephrol. 2024 Feb 6;2024:3292667. (PMID: 38352140) J Vasc Access. 2022 Mar;23(2):275-279. (PMID: 33487073) Open Forum Infect Dis. 2020 Apr 11;7(6):ofaa117. (PMID: 32550235) Nephrol Dial Transplant. 2016 Jun;31(6):864-7. (PMID: 26264780) J Vasc Access. 2018 Nov;19(6):602-608. (PMID: 29582680) BMJ Open. 2015 Nov 20;5(11):e007136. (PMID: 26589425) Rev Lat Am Enfermagem. 2010 Jan-Feb;18(1):73-80. (PMID: 20428700) Chin Med J (Engl). 2020 Apr 5;133(7):868-870. (PMID: 32097210) J Vasc Access. 2015 Sep-Oct;16(5):347-55. (PMID: 25907773) Int J Cardiol. 2017 Jul 1;238:151-158. (PMID: 28341375) Clin Kidney J. 2020 Jan 22;14(3):820-830. (PMID: 33777365) Am J Kidney Dis. 2014 Feb;63(2):259-67. (PMID: 24295613) Am J Kidney Dis. 2012 Jan;59(1):102-7. (PMID: 22088576) J Am Soc Nephrol. 2005 Sep;16(9):2769-77. (PMID: 16033861) Crit Care Med. 2011 Apr;39(4):613-20. (PMID: 21200319) J Bras Nefrol. 2016 Mar;38(1):70-5. (PMID: 27049367) Nat Rev Nephrol. 2011 May;7(5):257-65. (PMID: 21423251) Nephrol Dial Transplant. 2011 Aug;26(8):2611-7. (PMID: 21282302) Lancet. 2012 Jan 14;379(9811):165-80. (PMID: 21840587) Semin Dial. 2008 Nov-Dec;21(6):528-38. (PMID: 19000122) Saudi J Kidney Dis Transpl. 2018 Jan-Feb;29(1):120-126. (PMID: 29456217) Nephrol Dial Transplant. 2020 Mar 1;35(3):503-511. (PMID: 30107612) J Infect Public Health. 2017 Jul - Aug;10(4):403-408. (PMID: 27423929) Mater Sociomed. 2015 Apr;27(2):91-4. (PMID: 26005383) Int J Nephrol. 2012;2012:673954. (PMID: 22518313) |
| تواريخ الأحداث: | Date Created: 20240214 Latest Revision: 20240215 |
| رمز التحديث: | 20240215 |
| مُعرف محوري في PubMed: | PMC10864053 |
| DOI: | 10.1155/2024/3292667 |
| PMID: | 38352140 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2090-214X |
|---|---|
| DOI: | 10.1155/2024/3292667 |